Abstract | AIM: MATERIAL AND METHODS: GCF samples were collected from sites with GO (GO+) and without GO (GO-) in CsA patients having GO; and GO- sites in CsA patients having no GO; sites from tacrolimus, gingivitis and healthy subjects. GCF and serum MMP-8 and TIMP-1 levels were determined by a time-resolved immunofluorometric assay (IFMA) and enzyme-linked immunosorbent assay. RESULTS: GO+ sites in CsA patients having GO had elevated GCF MMP-8 levels compared with those of CsA patients having no GO, tacrolimus and healthy subjects (p<0.005), but these levels were similar to those of gingivitis. The GCF MMP-8 level was higher in GO+ compared with GO- sites in CsA patients having GO (p<0.05). GCF TIMP-1 levels were similar between groups. Tacrolimus patients had lower GCF MMP-8 levels than gingivitis (p<0.005), but levels similar to the healthy group. CONCLUSION: These results show that CsA and tacrolimus therapy has no significant effect on GCF MMP-8 levels, and gingival inflammation seems to be the main reason for their elevations.
|
Authors | Gülnur Emingil, Beral Afacan, Taina Tervahartiala, Hüseyin Töz, Gül Atilla, Timo Sorsa |
Journal | Journal of clinical periodontology
(J Clin Periodontol)
Vol. 35
Issue 3
Pg. 221-9
(Mar 2008)
ISSN: 1600-051X [Electronic] United States |
PMID | 18269661
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Immunosuppressive Agents
- Tissue Inhibitor of Metalloproteinase-1
- Cyclosporine
- Matrix Metalloproteinase 8
- Tacrolimus
|
Topics |
- Adolescent
- Adult
- Cyclosporine
(adverse effects)
- Epidemiologic Methods
- Female
- Gingival Crevicular Fluid
(chemistry)
- Gingival Overgrowth
(chemically induced, diagnostic imaging)
- Gingivitis
(diagnostic imaging)
- Humans
- Immunocompromised Host
- Immunosuppressive Agents
(adverse effects)
- Kidney Transplantation
(adverse effects)
- Male
- Matrix Metalloproteinase 8
(blood)
- Middle Aged
- Radiography
- Tacrolimus
(adverse effects)
- Tissue Inhibitor of Metalloproteinase-1
(blood)
|